Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells

Hao Shen(Eastern Hepatobiliary Surgery Hospital), Yao Chen(Central South University)

Acta Pharmacologica Sinica

May 4, 2022

10.1038/s41401-022-00907-5

Cited by 55

Related Papers

ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression

|Scientific Reports|2017|58

Akt Regulated Phosphorylation of GSK-3β/Cyclin D1, p21 and p27 Contributes to Cell Proliferation Through Cell Cycle Progression From G1 to S/G2M Phase in Low-Dose Arsenite Exposed HaCat Cells

|Frontiers in Pharmacology|2019|55